Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 160

1.

Longitudinal management with crossmatch-compatible platelets for refractory patients: alloimmunization, response to transfusion, and clinical outcomes (CME).

Wiita AP, Nambiar A.

Transfusion. 2012 Oct;52(10):2146-54. doi: 10.1111/j.1537-2995.2012.03593.x. Epub 2012 Mar 12.

PMID:
23113654
[PubMed - indexed for MEDLINE]
2.

Crossmatch-compatible platelets improve corrected count increments in patients who are refractory to randomly selected platelets.

Gelb AB, Leavitt AD.

Transfusion. 1997 Jun;37(6):624-30.

PMID:
9191823
[PubMed - indexed for MEDLINE]
3.

Recipient-derived HPA-1a antibodies: a cause of prolonged thrombocytopenia after unrelated donor stem cell transplantation.

Lucas G, Culliford S, Green F, Sidra G, Calvert A, Green A, Harrison P, Harvey J, Allen D, Smillie D, Masurekar A, Marks D, Russell N, Massey E.

Transfusion. 2010 Feb;50(2):334-9. doi: 10.1111/j.1537-2995.2009.02448.x. Epub 2009 Oct 23.

PMID:
19874563
[PubMed - indexed for MEDLINE]
4.

[An evaluation of platelet transfusion response using HLA crossmatch-compatible donors in patients with platelet refractoriness].

Hyun J, Lim YM, Park KD, Han BY, Kim YH, Han KS, Park MH.

Korean J Lab Med. 2009 Oct;29(5):481-9. doi: 10.3343/kjlm.2009.29.5.481. Korean.

PMID:
19893359
[PubMed - indexed for MEDLINE]
Free Article
5.

Platelets photochemically treated with amotosalen HCl and ultraviolet A light correct prolonged bleeding times in patients with thrombocytopenia.

Slichter SJ, Raife TJ, Davis K, Rheinschmidt M, Buchholz DH, Corash L, Conlan MG.

Transfusion. 2006 May;46(5):731-40.

PMID:
16686840
[PubMed - indexed for MEDLINE]
6.

A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology.

Mirasol Clinical Evaluation Study Group.

Transfusion. 2010 Nov;50(11):2362-75. doi: 10.1111/j.1537-2995.2010.02694.x.

PMID:
20492615
[PubMed - indexed for MEDLINE]
7.

A comparison of volume-reduced versus standard HLA/HPA-matched apheresis platelets in alloimmunized adult patients.

Honohan A, Tomson B, van der Bom J, de Vries R, Brand A.

Transfusion. 2012 Apr;52(4):742-51. doi: 10.1111/j.1537-2995.2011.03364.x. Epub 2011 Oct 7.

PMID:
21981629
[PubMed - indexed for MEDLINE]
8.

Platelet refractoriness and alloimmunization in pediatric oncology and bone marrow transplant patients.

Hogge DE, McConnell M, Jacobson C, Sutherland HJ, Benny WB, Massing BG.

Transfusion. 1995 Aug;35(8):645-52.

PMID:
7631404
[PubMed - indexed for MEDLINE]
9.

The value of crossmatch tests and panel tests as a screening tool to predict the outcome of platelet transfusion in a non-selected haematological population of patients.

Levin MD, van der Holt B, de Veld JC, Gratama JW, de Vries W, van't Veer MB.

Vox Sang. 2004 Nov;87(4):291-8.

PMID:
15585026
[PubMed - indexed for MEDLINE]
10.

A flow cytometric platelet immunofluorescence crossmatch for predicting successful HLA matched platelet transfusions.

Sintnicolaas K, Löwenberg B.

Br J Haematol. 1996 Mar;92(4):1005-10.

PMID:
8616059
[PubMed - indexed for MEDLINE]
11.

Utility of cross-matched platelet transfusions in patients with hypoproliferative thrombocytopenia: a systematic review.

Vassallo RR, Fung M, Rebulla P, Duquesnoy R, Saw CL, Slichter SJ, Tanael S, Shehata N; International Collaboration for Guideline Development, Implementation and Evaluation for Transfusion Therapies.

Transfusion. 2014 Apr;54(4):1180-91. doi: 10.1111/trf.12395. Epub 2013 Aug 27. Review.

PMID:
24032995
[PubMed - indexed for MEDLINE]
12.

An evaluation of crossmatching, HLA, and ABO matching for platelet transfusions to refractory patients.

Heal JM, Blumberg N, Masel D.

Blood. 1987 Jul;70(1):23-30.

PMID:
3474041
[PubMed - indexed for MEDLINE]
Free Article
13.

Independent roles for platelet crossmatching and HLA in the selection of platelets for alloimmunized patients.

Friedberg RC, Donnelly SF, Mintz PD.

Transfusion. 1994 Mar;34(3):215-20.

PMID:
8146893
[PubMed - indexed for MEDLINE]
14.

Comparison of transfusion efficacy of amotosalen-based pathogen-reduced platelet components and gamma-irradiated platelet components.

Sigle JP, Infanti L, Studt JD, Martinez M, Stern M, Gratwohl A, Passweg J, Tichelli A, Buser AS.

Transfusion. 2013 Aug;53(8):1788-97. doi: 10.1111/j.1537-2995.2012.03959.x. Epub 2012 Nov 26.

PMID:
23176347
[PubMed - indexed for MEDLINE]
15.

Platelet dose consistency and its effect on the number of platelet transfusions for support of thrombocytopenia: an analysis of the SPRINT trial of platelets photochemically treated with amotosalen HCl and ultraviolet A light.

Murphy S, Snyder E, Cable R, Slichter SJ, Strauss RG, McCullough J, Lin JS, Corash L, Conlan MG; SPRINT Study Group.

Transfusion. 2006 Jan;46(1):24-33.

PMID:
16398727
[PubMed - indexed for MEDLINE]
16.

Use of HLA- and HPA--matched platelets in alloimmunized patients.

Kekomäki R.

Vox Sang. 1998;74 Suppl 2:359-63. Review.

PMID:
9704468
[PubMed - indexed for MEDLINE]
17.

Evaluation of platelet transfusion triggers in a tertiary-care hospital.

Cameron B, Rock G, Olberg B, Neurath D.

Transfusion. 2007 Feb;47(2):206-11.

PMID:
17302765
[PubMed - indexed for MEDLINE]
18.

The role of alloantibodies against human platelet antigen-15 in multiply platelet transfused patients.

Matsuhashi M, Tsuno NH, Sone S, Mishima Y, Nagura Y, Watanabe-Okochi N, Ikeda T, Kashiwase K, Fukuda S, Iriyama T, Hyodo H, Yamashita T, Kamei Y, Arai S, Minami M, Fujii T, Kurokawa M, Tozuka M, Takahashi K, Santoso S.

Transfusion. 2014 Apr;54(4):1093-9. doi: 10.1111/trf.12455. Epub 2013 Oct 22.

PMID:
24147542
[PubMed - indexed for MEDLINE]
19.

[Application of microcolumn gel immunoassay in screening the platelet antibody].

Xu DY, Dong GF, Zhang Z, Peng MX, Du Y, Chen CS, Tang XX, Fu JY, Gao JL, Bai J, Ma YL, Qian BY, Ma JB.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007 Aug;15(4):888-91. Chinese.

PMID:
17708827
[PubMed - indexed for MEDLINE]
20.

Therapeutic efficacy and safety of photochemically treated apheresis platelets processed with an optimized integrated set.

Janetzko K, Cazenave JP, Klüter H, Kientz D, Michel M, Beris P, Lioure B, Hastka J, Marblie S, Mayaudon V, Lin L, Lin JS, Conlan MG, Flament J.

Transfusion. 2005 Sep;45(9):1443-52.

PMID:
16131376
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk